Public Profile

Ionis Pharmaceuticals

Ionis Pharmaceuticals, Inc., a leading biotechnology company headquartered in the United States, is renowned for its pioneering work in RNA-targeted therapeutics. Founded in 1989, Ionis has established itself as a key player in the pharmaceutical industry, focusing on the development of innovative treatments for a range of serious diseases, including neurological disorders and cardiovascular conditions. With a robust pipeline of drugs, Ionis is particularly noted for its unique antisense technology, which allows for precise modulation of gene expression. This innovative approach has led to significant milestones, including the approval of several groundbreaking therapies. Ionis Pharmaceuticals continues to strengthen its market position through strategic partnerships and a commitment to advancing the field of genetic medicine, making it a notable force in the biopharmaceutical landscape.

DitchCarbon Score

How does Ionis Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Ionis Pharmaceuticals's score of 20 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Ionis Pharmaceuticals's reported carbon emissions

In 2023, Ionis Pharmaceuticals reported total carbon emissions of approximately 5,483,000 kg CO2e, comprising 2,695,000 kg CO2e from Scope 1 and 2,788,000 kg CO2e from Scope 2 emissions. This represents a slight increase from 2022, where emissions were about 4,297,000 kg CO2e, with Scope 1 emissions at 2,456,000 kg CO2e and Scope 2 at 1,841,000 kg CO2e. In 2021, the company recorded total emissions of approximately 4,618,000 kg CO2e, with Scope 1 at 2,566,000 kg CO2e and Scope 2 at 2,052,000 kg CO2e. Despite these figures, Ionis Pharmaceuticals has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has reported emissions intensity metrics, with approximately 6,110 kg CO2e per employee in 2023, down from 7,220 kg CO2e in 2021, indicating a potential focus on improving operational efficiency. As of now, Ionis Pharmaceuticals has not committed to any science-based targets or climate pledges, which places them in a broader industry context where many companies are increasingly adopting ambitious climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
2,566,000
0,000,000
0,000,000
Scope 2
2,052,000,000
0,000,000,000
0,000,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ionis Pharmaceuticals's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Ionis Pharmaceuticals is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ionis Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Fulcrum Therapeutics, Inc.

US
Health and social work services (85)
Updated 22 days ago

Pharming Group N.V.

NL
Health and social work services (85)
Updated about 8 hours ago

Alexion Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated about 2 months ago
DitchCarbon Score

BCR

CR
Fabricated metal products, except machinery and equipment (28)
Updated 26 days ago

Biogen

US
Research and development services (73)
Updated 5 days ago

Wave Life Sciences Ltd.

SG
Health and social work services (85)
Updated 20 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers